How can I tell if an online compounded semaglutide pharmacy is FDA compliant?

Short answer: there’s no single “FDA seal” for compounded drugs. To judge whether an online compounding pharmacy making semaglutide is operating lawfully and safely, use a checklist of credentials, documentation, and behavior — and prefer getting FDA‑approved products through well‑known pharmacies when possible.

Checklist — what to verify and how

• Valid pharmacy license: check the pharmacy’s current license with the state Board of Pharmacy where the pharmacy is located. Ask for the license number and confirm it on the state board website.
  Why: compounding pharmacies must be licensed by their state.

• NABP / VIPPS and PharmacyChecker: search the National Association of Boards of Pharmacy (NABP) for disciplinary actions and consult PharmacyChecker for verification of internet pharmacy legitimacy. NABP also publishes a “Not Recommended” list.
  Why: NABP aggregates regulatory actions and PharmacyChecker screens online pharmacies.

• 503A vs 503B status (important): find out whether the facility is a 503A compounding pharmacy (makes patient‑specific scripts under state rules) or a 503B outsourcing facility (can make larger batches and must register with FDA and follow cGMP). If they claim 503B, confirm the company appears on the FDA’s current list of registered outsourcing facilities.
  Why: 503B facilities are subject to FDA registration and inspections; 503A pharmacies are regulated by state boards.

• Accreditation (PCAB/ACHC or USP-based): check for accreditation from the Accreditation Commission for Health Care (ACHC) / PCAB or other recognized compounding accreditors and whether they follow USP standards (USP <797> for sterile compounding, USP <71> sterility testing, USP <85> endotoxin testing).
  Why: accredited pharmacies meet higher, independently verified sterile compounding standards.

• Sterility and potency testing, batch records, CoAs: ask the pharmacy to provide lot‑specific Certificates of Analysis (CoA) for the active pharmaceutical ingredient (API) and finished product testing (potency assay, sterility, bacterial endotoxin test). For injectables, ask for evidence of aseptic environment (ISO certification), sterility test results, and stability/shelf‑life data.
  Why: injectable peptides are high‑risk — independent testing & CoAs are critical.

• Source of API and legal basis for compounding: ask whether they compound from an FDA‑approved drug product (e.g., use an approved vial/supply) or from bulk API. Many regulators and the FDA are concerned about compounding from bulk APIs for complex peptides/biologics. If they use bulk API, ask for supplier CoAs and proof that the supplier is legitimate.
  Why: compounding from bulk API for drugs like semaglutide raises safety and regulatory issues; FDA has warned against inappropriate compounding of biologics.

• Prescription requirement and clinician oversight: they must require a valid prescription from a licensed prescriber or perform a legitimate telemedicine evaluation tied to a specific patient. Beware services that ship without a proper prescription.
  Why: lawful compounding normally requires a patient‑specific prescription.

• Contact info, pharmacist availability & transparency: there should be a physical address, phone number, licensed pharmacist available for questions, and clear policies on returns and adverse event reporting. No anonymous or offshore‑only contact info.
  Why: transparency is a hallmark of legitimate pharmacies.

Red flags (walk away or escalate)

• No prescription required, or it’s easy to bypass.
• Extremely low price or claims of “exact brand substitute” when the brand exists.
• No license or they refuse to provide/allow you to verify it.
• No batch CoAs, no sterility testing, or refusal to discuss USP <797> compliance.
• Offshore shipping or ambiguous “fulfillment” locations.
• No pharmacist contact or no physical address.

Who and where to check (specific names/services)

• FDA: check the “Outsourcing Facility” registration list and search FDA Warning Letters / Enforcement Actions for the pharmacy name.
• National Association of Boards of Pharmacy (NABP): search for disciplinary actions and the “Not Recommended” list.
• State Board of Pharmacy where the pharmacy is located: verify license status.
• ACHC / PCAB accreditation: ask whether the pharmacy is PCAB‑accredited (now under ACHC) and confirm.
• U.S. Pharmacopeia (USP) standards: verify the pharmacy follows USP <797>, <71>, <85> requirements.
• PharmacyChecker: independent service that screens online pharmacies (not an FDA approval but useful for screening).
• Valisure: independent laboratory that chemically tests medications — you can look for public testing reports for similar products or ask whether the pharmacy uses third‑party lab testing.

Safer alternatives

• Prefer the FDA‑approved products (Ozempic, Wegovy, Rybelsus for semaglutide) filled through major, reputable pharmacies like CVS Pharmacy, Walgreens, Walmart Pharmacy, Costco, or specialty pharmacies (Accredo, OptumRx) that dispense manufacturer product. These pharmacies are subject to state and federal oversight and typically don’t compound complex injectables.
• Use a reputable telemedicine or weight‑management service that partners with legitimate pharmacies and provides proper evaluation (examples: Ro, Hims & Hers, PlushCare — verify that any prescriptions are sent to a licensed pharmacy you can confirm).

If you’re unsure or suspicious

• Contact the state Board of Pharmacy to ask whether they have complaints or inspections on record for that pharmacy.
• Search FDA warning letters/enforcement actions for the pharmacy name.
• Don’t use an injectable product unless you can verify sterility testing and CoAs — injectable contamination can be dangerous.
• Report suspicious or unsafe pharmacies to FDA MedWatch and the state Board of Pharmacy.

Bottom line Compounded semaglutide carries extra regulatory and safety concerns because it’s a peptide injectable. An FDA‑compliant 503B outsourcing facility with ACHC/PCAB accreditation, visible state licenses, batch CoAs and sterility/potency testing, and a requirement for a valid prescription is as close to “safe and compliant” as you can expect. If any of those elements are missing, choose an FDA‑approved product through a known retail or specialty pharmacy instead and discuss options with your prescriber.